Published in Arch Intern Med on April 28, 2008
Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation (2008) 2.33
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07
Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause (2011) 1.72
History of hot flashes and aortic calcification among postmenopausal women. Menopause (2010) 1.63
Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause (2015) 1.47
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy. Menopause (2009) 1.24
Vasomotor symptoms and insulin resistance in the study of women's health across the nation. J Clin Endocrinol Metab (2012) 1.13
Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer. BMC Cancer (2010) 1.06
Personality, Menopausal Symptoms, and Physical Activity Outcomes in Middle-Aged Women. Pers Individ Dif (2009) 1.05
Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors. Menopause (2010) 0.94
The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women. J Gen Intern Med (2009) 0.81
Device-guided slow-paced respiration for menopausal hot flushes: a randomized controlled trial. Obstet Gynecol (2015) 0.76
Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial. Menopause (2016) 0.75
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14
Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36
The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med (2006) 3.93
Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med (2006) 3.71
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56
Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 3.50
Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev (2005) 3.20
Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med (2008) 3.20
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev (2005) 3.01
Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med (2011) 3.00
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86
A drug burden index to define the functional burden of medications in older people. Arch Intern Med (2007) 2.84
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69
The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol (2006) 2.64
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62
Diagnostic tests: another frontier for less is more: or why talking to your patient is a safe and effective method of reassurance. Arch Intern Med (2010) 2.49
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43
Relationship of changes in physical activity and mortality among older women. JAMA (2003) 2.42
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41
Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res (2010) 2.29
Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med (2011) 2.27
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med (2003) 2.20
Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol (2003) 2.19
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10
Association of major and minor ECG abnormalities with coronary heart disease events. JAMA (2012) 2.07
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07
Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA (2011) 2.04
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ (2009) 2.00
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 1.98
Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clin Proc (2002) 1.97
Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol (2005) 1.94
Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res (2004) 1.93
Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood (2007) 1.92
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res (2012) 1.92
Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med (2009) 1.91
Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res (2007) 1.88
Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol (2003) 1.85
Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82
Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study. Ann Intern Med (2003) 1.81
Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81
NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements (2013) 1.81
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med (2012) 1.80
Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation (2012) 1.79
Continuing bisphosphonate treatment for osteoporosis--for whom and for how long? N Engl J Med (2012) 1.79
Less is more: how less health care can result in better health. Arch Intern Med (2010) 1.77
Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab (2006) 1.76
Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology (2006) 1.75
Predictors of heart failure among women with coronary disease. Circulation (2004) 1.74
Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int (2008) 1.71
Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med (2009) 1.71
The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. J Bone Miner Res (2011) 1.70
Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst (2006) 1.70
Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med (2008) 1.70
USPSTF recommendations for STI screening. Am Fam Physician (2008) 1.68
Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom (2008) 1.66
Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol (2006) 1.66
Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med (2011) 1.64
Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci (2009) 1.64
Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res (2004) 1.64
HPV vaccination--more answers, more questions. N Engl J Med (2007) 1.64
The WHI estrogen-alone trial--do things look any better? JAMA (2004) 1.64
Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res (2006) 1.63
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2015) 1.63
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause (2009) 1.63
Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry (2005) 1.62
Sex hormone levels and risk of breast cancer with estrogen plus progestin. J Natl Cancer Inst (2013) 1.60
Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax (2011) 1.60
Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol (2004) 1.59
Sleep disturbances and risk of frailty and mortality in older men. Sleep Med (2012) 1.58
Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol (2002) 1.57
Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI). J Bone Miner Res (2011) 1.55
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol (2008) 1.55
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes (2013) 1.55
Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study. Am Heart J (2010) 1.54
Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab (2004) 1.54
The "costs" of urinary incontinence for women. Obstet Gynecol (2006) 1.52
Sex hormones and the risk of incident prostate cancer. Urology (2010) 1.52
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol (2012) 1.52
Opioids for chronic pain. Arch Intern Med (2011) 1.52
Antihypertensive drug class use and differential risk of urinary incontinence in community-dwelling older women. J Gerontol A Biol Sci Med Sci (2012) 1.50